The Adverse Effects and Therapeutic Potential of Psychedelic Medicines

by
Format: Nonspecific Binding
Pub. Date: 2026-05-05
Publisher(s): Simon & Schuster
  • Free Shipping Icon

    Free Shipping On All Orders!*

    Free economy shipping applies to all orders shipped to residential addresses. Orders shipped to campus receive free standard shipping. Free shipping offers do not apply to Marketplace items.

List Price: $29.32

Buy New

Usually Ships in 5-7 Business Days
$29.29

Rent Textbook

Select for Price
There was a problem. Please try again later.

Used Textbook

We're Sorry
Sold Out

eTextbook

We're Sorry
Not Available

How Marketplace Works:

  • This item is offered by an independent seller and not shipped from our warehouse
  • Item details like edition and cover design may differ from our description; see seller's comments before ordering.
  • Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
  • Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
  • Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.

Summary

• Draws on current research, interviews, and case studies to detail the risks and benefits of psychedelics like LSD, psilocybin, MDMA, ketamine, and mescaline

• Explores the short- and long-term effects of psychedelics, looking at heart rate, blood pressure, and markers of mental health

• Includes in-depth profiles of psychedelics, considering their chemical composition, effects, safety considerations, and legal status

The psychedelic renaissance has been opening new therapeutic modalities in Western medicine. With the potential to reduce our reliance on pharmaceuticals and improve overall well-being, the use of psychedelics has yielded promising results. However, the increased acceptance and use of these age-old medicines should also be approached with caution and full awareness.

Clinical psychologist, Richard Louis Miller, provides a balanced analysis of the risks and benefits of psychedelics to ensure their responsible use. He comprehensively details the rewards and potential complications of substances like LSD, psilocybin, ayahuasca, DMT, MDMA, and ketamine to provide thorough risk profiles and a working guide for psychedelic-informed therapy.

Drawing on the latest research, interviews with practitioners, and case studies, Miller considers physiological effects like nausea, altered heart rate, and blood pressure changes, along with mental effects including anxiety, reality distortion, and mood disorders often associated with a bad trip. The book includes in-depth profiles on psychedelic substances detailing their chemical composition, safety considerations, and legal status.

As psychedelics become more accepted as medicines, it is important that we become fully knowledgeable about their effects. By revealing the benefits and risks, this book is a key resource in the ethical and responsible use of psychedelics.

Author Biography

Dr. Richard Louis Miller has been a clinical psychologist for more than 50 years, and is host of the radio show Mind Body Health & Politics. The founder of the Cokenders Alcohol and Drug Program, he is a former faculty member at the University of Michigan and Stanford University. He lives in Fort Bragg and Wilbur Hot Springs, California.

Table of Contents

PROLOGUE The Space Between Hope and Caution,
Promise and Peril

PART 1
The Promises and Pitfalls of the
Psychedelic Renaissance

ONE Full Transparency

TWO Understanding Psychedelic Substances

PART 2
Acute Adverse Effects

THREE Mental Adverse Effects

FOUR Somatic Challenges

PART 3
Prolonged Adverse Effects

FIVE Prolonged Perceptual Changes

SIX Long-Term Psychological and
Existential Disturbances

SEVEN
The Enigma of Recovered Memories

PART 4
The Crucial Need for
Professional Standards


EIGHT Abuse of Patient Trust in Psychedelic Therapy

NINE Ramifications of an Unsafe Environment

TEN Harm Reduction—From Theory to Practice

ELEVEN Integration

TWELVE The Way Forward

Resources for Psychedelic Safety, Research,
and Integration

Guide to Psychedelic Clinical Profiles

2C-B (2,5-dimethoxy-4-bromophenethylamine)

5-APB (5-(2-Aminopropyl)benzofuran)

5-MeO-DMT (5-methoxy-N,N-dimethyltryptamine)

Ayahuasca

DMT (N,N-Dimethyltryptamine)

DOM (2,5-Dimethoxy-4-methylamphetamine)

Ibogaine

Ketamine (2-(2-chlorophenyl)-2-(methylamino)
cyclohexanone)

LSD (Lysergic Acid Diethylamide)

MDMA (3,4-Methylenedioxymethamphetamine)

Mescaline (3,4,5-trimethoxyphenethylamine)

Psilocybin Mushrooms

Salvia divinorum / Salvinorin A

References

Index

An electronic version of this book is available through VitalSource.

This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.

By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.

Digital License

You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.

More details can be found here.

A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.

Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.

Please view the compatibility matrix prior to purchase.